INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 34 filers reported holding INMUNE BIO INC in Q2 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,416 | -29.0% | 85,441 | -5.7% | 0.00% | – |
| Q2 2023 | $822,748 | +80.3% | 90,611 | +28.3% | 0.00% | – |
| Q1 2023 | $456,315 | +195.0% | 70,637 | +189.6% | 0.00% | – |
| Q4 2022 | $154,658 | -61.6% | 24,394 | -62.5% | 0.00% | – |
| Q3 2022 | $403,000 | +72.2% | 64,973 | +145.2% | 0.00% | – |
| Q2 2022 | $234,000 | -46.6% | 26,500 | -49.1% | 0.00% | – |
| Q1 2022 | $438,000 | -76.3% | 52,042 | -71.3% | 0.00% | – |
| Q4 2021 | $1,848,000 | -43.0% | 181,156 | +8.6% | 0.00% | – |
| Q3 2021 | $3,240,000 | +143.6% | 166,829 | +120.3% | 0.00% | – |
| Q2 2021 | $1,330,000 | +238.4% | 75,714 | +128.9% | 0.00% | – |
| Q1 2021 | $393,000 | +934.2% | 33,072 | +189.0% | 0.00% | – |
| Q1 2020 | $38,000 | – | 11,443 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 275,000 | $5,341,000 | 2.77% |
| Fermata Advisors, LLC | 12,830 | $249,000 | 0.11% |
| DG Capital Management, LLC | 20,000 | $388,000 | 0.08% |
| YorkBridge Wealth Partners, LLC | 10,369 | $201,000 | 0.05% |
| Ikarian Capital, LLC | 26,632 | $517,000 | 0.04% |
| Financial Advocates Investment Management | 16,667 | $324,000 | 0.02% |
| Janney Montgomery Scott LLC | 99,323 | $1,929,000 | 0.01% |
| Belvedere Trading LLC | 16,177 | $302,000 | 0.01% |
| FNY Investment Advisers, LLC | 800 | $15,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 17,200 | $334,000 | 0.01% |